{"transactions":[{"id":4629069,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-10-02T21:37:29.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":627,"price":26.33,"value":16508.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."}],"balance_after":20598,"source":{"system":"sec-edgar","filing":"0001966716-26-000014","document":"form4-10022026_091025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966716/000196671626000014/form4-10022026_091025.xml","form_type":"4"}},{"id":683465,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Performance Stock Units","published_at":"2026-08-19T00:27:22.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Achievement of this performance stock unit award was certified on August 14, 2025.  Pursuant to the terms of the award agreement between the reporting person and the Issuer, half the award vested on August 14, 2025 and the remainder vests on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001966716-26-000012","document":"form4-08192026_120818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000012/form4-08192026_120818.xml","form_type":"4"}},{"id":683464,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-08-19T00:27:22.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":145,"price":32.4681,"value":4707.8745,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.44 to $32.54 per share, inclusive."}],"balance_after":21225,"source":{"system":"sec-edgar","filing":"0001966716-26-000012","document":"form4-08192026_120818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000012/form4-08192026_120818.xml","form_type":"4"}},{"id":683463,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-08-19T00:27:22.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":2716,"price":32.0072,"value":86931.5552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.40 to $32.36 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":21370,"source":{"system":"sec-edgar","filing":"0001966716-26-000012","document":"form4-08192026_120818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000012/form4-08192026_120818.xml","form_type":"4"}},{"id":683462,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-08-19T00:27:22.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24086,"source":{"system":"sec-edgar","filing":"0001966716-26-000012","document":"form4-08192026_120818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000012/form4-08192026_120818.xml","form_type":"4"}},{"id":732065,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-06-18T20:18:58.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":1457,"price":29.95,"value":43637.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."}],"balance_after":18086,"source":{"system":"sec-edgar","filing":"0001966716-26-000010","document":"form4-06182026_080652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000010/form4-06182026_080652.xml","form_type":"4"}},{"id":829251,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-24T20:19:20.000Z","date":"2026-03-20","kind":"sale","planned":true,"acquired":false,"shares":601,"price":34.4079,"value":20679.1479,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.34 to $35.12 per share, inclusive."}],"balance_after":19543,"source":{"system":"sec-edgar","filing":"0001966716-26-000008","document":"form4-03242026_080316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000008/form4-03242026_080316.xml","form_type":"4"}},{"id":829250,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-24T20:19:20.000Z","date":"2026-03-20","kind":"sale","planned":true,"acquired":false,"shares":8692,"price":33.6354,"value":292358.8968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.33 to $34.28 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":20144,"source":{"system":"sec-edgar","filing":"0001966716-26-000008","document":"form4-03242026_080316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000008/form4-03242026_080316.xml","form_type":"4"}},{"id":833436,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-19T21:57:09.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":72,"price":32.85,"value":2365.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."}],"balance_after":28836,"source":{"system":"sec-edgar","filing":"0001966716-26-000006","document":"form4-03192026_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/form4-03192026_090304.xml","form_type":"4"}},{"id":833435,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-19T21:57:09.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":334,"price":31.7888,"value":10617.4592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.46 per share, inclusive."}],"balance_after":28908,"source":{"system":"sec-edgar","filing":"0001966716-26-000006","document":"form4-03192026_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/form4-03192026_090304.xml","form_type":"4"}},{"id":833434,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-19T21:57:09.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":4222,"price":31.2838,"value":132080.2036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $31.58 per share, inclusive."}],"balance_after":29242,"source":{"system":"sec-edgar","filing":"0001966716-26-000006","document":"form4-03192026_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/form4-03192026_090304.xml","form_type":"4"}},{"id":833433,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-19T21:57:09.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":1791,"price":33.3754,"value":59775.3414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.855 per share, inclusive."}],"balance_after":33464,"source":{"system":"sec-edgar","filing":"0001966716-26-000006","document":"form4-03192026_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/form4-03192026_090304.xml","form_type":"4"}},{"id":833432,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-19T21:57:09.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":2476,"price":32.7394,"value":81062.7544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.995 to $32.99 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4."}],"balance_after":35255,"source":{"system":"sec-edgar","filing":"0001966716-26-000006","document":"form4-03192026_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/form4-03192026_090304.xml","form_type":"4"}},{"id":837847,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":36000,"derivative":{"expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837846,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":12000,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837845,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":7475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":7475,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7475},"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837844,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37731,"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837843,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25731,"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837842,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":7475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported total includes an aggregate 425 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":19731,"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":893326,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T21:20:07.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU award shall vest as to 1/4 of the total award annually with the first tranche vesting on February 15, 2027, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":35000,"derivative":{"expiration_date":"2030-02-15","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001966716-26-000002","document":"form4-02192026_090202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000002/form4-02192026_090202.xml","form_type":"4"}},{"id":893325,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-19T21:20:07.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":53000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/48 of the total award on March 15, 2026, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":53000,"derivative":{"exercise_price":31.09,"expiration_date":"2036-02-16","underlying":"Common Stock","underlying_shares":53000},"source":{"system":"sec-edgar","filing":"0001966716-26-000002","document":"form4-02192026_090202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000002/form4-02192026_090202.xml","form_type":"4"}},{"id":974390,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-10T21:24:33.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":2678,"price":32.6128,"value":87337.0784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.29 to $33.19 per share, inclusive."}],"balance_after":11831,"source":{"system":"sec-edgar","filing":"0001966716-25-000009","document":"form4-12102025_091230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000009/form4-12102025_091230.xml","form_type":"4"}},{"id":974389,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-10T21:24:33.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":1300,"price":31.5956,"value":41074.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.27 to $32.14 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":14509,"source":{"system":"sec-edgar","filing":"0001966716-25-000009","document":"form4-12102025_091230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000009/form4-12102025_091230.xml","form_type":"4"}},{"id":978994,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Performance Stock Units","published_at":"2025-12-06T01:49:23.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Half the award vested on December 3, 2024 and the remainder vested or vests on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001966716-25-000008","document":"form4-12062025_011219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000008/form4-12062025_011219.xml","form_type":"4"}},{"id":978993,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-06T01:49:23.000Z","date":"2025-12-05","kind":"sale","planned":true,"acquired":false,"shares":2344,"price":31.7597,"value":74444.7368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.59 to $31.97 per share, inclusive."}],"balance_after":15809,"source":{"system":"sec-edgar","filing":"0001966716-25-000008","document":"form4-12062025_011219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000008/form4-12062025_011219.xml","form_type":"4"}},{"id":978992,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-06T01:49:23.000Z","date":"2025-12-05","kind":"sale","planned":true,"acquired":false,"shares":5437,"price":31.0828,"value":168997.1836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.58 to $31.57 per share, inclusive."}],"balance_after":18153,"source":{"system":"sec-edgar","filing":"0001966716-25-000008","document":"form4-12062025_011219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000008/form4-12062025_011219.xml","form_type":"4"}},{"id":978991,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-06T01:49:23.000Z","date":"2025-12-05","kind":"sale","planned":true,"acquired":false,"shares":1004,"price":31.3304,"value":31455.7216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.93 to $31.69 per share, inclusive."}],"balance_after":23590,"source":{"system":"sec-edgar","filing":"0001966716-25-000008","document":"form4-12062025_011219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000008/form4-12062025_011219.xml","form_type":"4"}},{"id":978990,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-06T01:49:23.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":194,"price":31.3164,"value":6075.3816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.23 to $31.505 per share, inclusive."}],"balance_after":24594,"source":{"system":"sec-edgar","filing":"0001966716-25-000008","document":"form4-12062025_011219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000008/form4-12062025_011219.xml","form_type":"4"}},{"id":978989,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-06T01:49:23.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":824,"price":30.7635,"value":25349.124,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.23 to $31.19 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3, 4, 6, and 7 of this Form 4."}],"balance_after":24788,"source":{"system":"sec-edgar","filing":"0001966716-25-000008","document":"form4-12062025_011219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000008/form4-12062025_011219.xml","form_type":"4"}},{"id":978988,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-06T01:49:23.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25612,"source":{"system":"sec-edgar","filing":"0001966716-25-000008","document":"form4-12062025_011219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000008/form4-12062025_011219.xml","form_type":"4"}},{"id":981478,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2025-12-04T01:20:26.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":false,"shares":12357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"33,927 restricted stock units from this award vested on December 1, 2024 and 12,357 vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date."}],"balance_after":0,"derivative":{"expiration_date":"2025-12-01","underlying":"Common Stock","underlying_shares":12357},"source":{"system":"sec-edgar","filing":"0001966716-25-000006","document":"form4-12042025_011223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000006/form4-12042025_011223.xml","form_type":"4"}},{"id":981477,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-04T01:20:26.000Z","date":"2025-12-03","kind":"sale","planned":false,"acquired":false,"shares":1394,"price":30.8477,"value":43001.6938,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.815 to $31.17 per share, inclusive."}],"balance_after":19612,"source":{"system":"sec-edgar","filing":"0001966716-25-000006","document":"form4-12042025_011223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000006/form4-12042025_011223.xml","form_type":"4"}},{"id":981476,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-04T01:20:26.000Z","date":"2025-12-03","kind":"sale","planned":false,"acquired":false,"shares":898,"price":30.338,"value":27243.524,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.81 to $30.805 per share, inclusive."}],"balance_after":21006,"source":{"system":"sec-edgar","filing":"0001966716-25-000006","document":"form4-12042025_011223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000006/form4-12042025_011223.xml","form_type":"4"}},{"id":981475,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-04T01:20:26.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":868,"price":30.1419,"value":26163.1692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.93 to $30.63 per share, inclusive."}],"balance_after":21904,"source":{"system":"sec-edgar","filing":"0001966716-25-000006","document":"form4-12042025_011223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000006/form4-12042025_011223.xml","form_type":"4"}},{"id":981474,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-04T01:20:26.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":1416,"price":29.562,"value":41859.792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.93 to $29.92 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5."}],"balance_after":22772,"source":{"system":"sec-edgar","filing":"0001966716-25-000006","document":"form4-12042025_011223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000006/form4-12042025_011223.xml","form_type":"4"}},{"id":981473,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-12-04T01:20:26.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":true,"shares":12357,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24188,"source":{"system":"sec-edgar","filing":"0001966716-25-000006","document":"form4-12042025_011223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000006/form4-12042025_011223.xml","form_type":"4"}},{"id":1022191,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T20:26:05.000Z","date":"2025-10-03","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested or vests as to 1/48th of the total award on April 15, 2023, with an additional 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":34800,"derivative":{"exercise_price":9.15,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001966716-25-000004","document":"form4-10072025_081001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000004/form4-10072025_081001.xml","form_type":"4"}},{"id":1022190,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-10-07T20:26:05.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":25.065,"value":250650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11831,"source":{"system":"sec-edgar","filing":"0001966716-25-000004","document":"form4-10072025_081001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000004/form4-10072025_081001.xml","form_type":"4"}},{"id":1022189,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-10-07T20:26:05.000Z","date":"2025-10-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":9.15,"value":91500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."}],"balance_after":21831,"source":{"system":"sec-edgar","filing":"0001966716-25-000004","document":"form4-10072025_081001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671625000004/form4-10072025_081001.xml","form_type":"4"}},{"id":1049561,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T21:50:21.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":false,"shares":9150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested or vests as to 1/48th of the total award on January 7, 2023, with 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":15801,"derivative":{"exercise_price":7.07,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":9150},"source":{"system":"sec-edgar","filing":"0001415889-25-023589","document":"form4-09032025_090917.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023589/form4-09032025_090917.xml","form_type":"4"}},{"id":1049560,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T21:50:21.000Z","date":"2025-08-29","kind":"exercise","planned":true,"acquired":false,"shares":850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested or vests as to 1/48th of the total award on January 7, 2023, with 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":24951,"derivative":{"exercise_price":7.07,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":850},"source":{"system":"sec-edgar","filing":"0001415889-25-023589","document":"form4-09032025_090917.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023589/form4-09032025_090917.xml","form_type":"4"}},{"id":1049559,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-09-03T21:50:21.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":6345,"price":20.0657,"value":127316.8665,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.20, inclusive."}],"balance_after":11831,"source":{"system":"sec-edgar","filing":"0001415889-25-023589","document":"form4-09032025_090917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023589/form4-09032025_090917.xml","form_type":"4"}},{"id":1049558,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-09-03T21:50:21.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":14922,"price":20.1375,"value":300491.775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":18176,"source":{"system":"sec-edgar","filing":"0001415889-25-023589","document":"form4-09032025_090917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023589/form4-09032025_090917.xml","form_type":"4"}},{"id":1049557,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-09-03T21:50:21.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":true,"shares":9150,"price":7.07,"value":64690.5,"ownership":{"direct":true},"balance_after":33098,"source":{"system":"sec-edgar","filing":"0001415889-25-023589","document":"form4-09032025_090917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023589/form4-09032025_090917.xml","form_type":"4"}},{"id":1049556,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-09-03T21:50:21.000Z","date":"2025-08-29","kind":"sale","planned":true,"acquired":false,"shares":850,"price":20,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."}],"balance_after":23948,"source":{"system":"sec-edgar","filing":"0001415889-25-023589","document":"form4-09032025_090917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023589/form4-09032025_090917.xml","form_type":"4"}},{"id":1049555,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-09-03T21:50:21.000Z","date":"2025-08-29","kind":"exercise","planned":true,"acquired":true,"shares":850,"price":7.07,"value":6009.5,"ownership":{"direct":true},"balance_after":24798,"source":{"system":"sec-edgar","filing":"0001415889-25-023589","document":"form4-09032025_090917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023589/form4-09032025_090917.xml","form_type":"4"}},{"id":1060213,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-08-20T20:11:05.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1683,"price":18.238,"value":30694.554,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.50 per share, inclusive."}],"balance_after":23948,"source":{"system":"sec-edgar","filing":"0001415889-25-022440","document":"form4-08202025_080802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925022440/form4-08202025_080802.xml","form_type":"4"}},{"id":1063880,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Performance Stock Units","published_at":"2025-08-19T00:24:34.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Half the award vests on August 14, 2025 and the remainder shall vest on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":6000,"derivative":{"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001415889-25-022226","document":"form4-08192025_120830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925022226/form4-08192025_120830.xml","form_type":"4"}},{"id":1063879,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Performance Stock Units","published_at":"2025-08-19T00:24:34.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This award represents a grant of restricted stock units upon the achievement of certain performance criteria as certified by the Issuer's compensation committee on the Transaction Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Half the award vests on August 14, 2025 and the remainder shall vest on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":12000,"derivative":{"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001415889-25-022226","document":"form4-08192025_120830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925022226/form4-08192025_120830.xml","form_type":"4"}},{"id":1063878,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-08-19T00:24:34.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25631,"source":{"system":"sec-edgar","filing":"0001415889-25-022226","document":"form4-08192025_120830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925022226/form4-08192025_120830.xml","form_type":"4"}},{"id":1065316,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-08-15T20:31:44.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":13712,"price":15,"value":205680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported total includes an aggregate 1,778 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":19631,"source":{"system":"sec-edgar","filing":"0001415889-25-022074","document":"form4-08152025_080840.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925022074/form4-08152025_080840.xml","form_type":"4"}},{"id":1195678,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2025-03-20T22:05:38.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The award vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":48000,"derivative":{"expiration_date":"2029-03-20","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001415889-25-008709","document":"form4-03202025_100334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008709/form4-03202025_100334.xml","form_type":"4"}},{"id":1195677,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-20T22:05:38.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shall vest as to 1/48 of the total award on April 15, 2025, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":72000,"derivative":{"exercise_price":8.33,"expiration_date":"2035-03-19","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001415889-25-008709","document":"form4-03202025_100334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008709/form4-03202025_100334.xml","form_type":"4"}},{"id":1195676,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-20T22:05:38.000Z","date":"2025-03-19","kind":"sale","planned":false,"acquired":false,"shares":1945,"price":8.27,"value":16085.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.06 to $8.95 per share, inclusive."}],"balance_after":31565,"source":{"system":"sec-edgar","filing":"0001415889-25-008709","document":"form4-03202025_100334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008709/form4-03202025_100334.xml","form_type":"4"}},{"id":1195675,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-20T22:05:38.000Z","date":"2025-03-18","kind":"sale","planned":false,"acquired":false,"shares":2266,"price":8.67,"value":19646.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.11 to $8.925 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnote 3."}],"balance_after":33510,"source":{"system":"sec-edgar","filing":"0001415889-25-008709","document":"form4-03202025_100334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008709/form4-03202025_100334.xml","form_type":"4"}},{"id":1199733,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2025-03-18T20:11:54.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":18000,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001415889-25-008367","document":"form4-03182025_080351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008367/form4-03182025_080351.xml","form_type":"4"}},{"id":1199732,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2025-03-18T20:11:54.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":7475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":14950,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7475},"source":{"system":"sec-edgar","filing":"0001415889-25-008367","document":"form4-03182025_080351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008367/form4-03182025_080351.xml","form_type":"4"}},{"id":1199731,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-18T20:11:54.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35776,"source":{"system":"sec-edgar","filing":"0001415889-25-008367","document":"form4-03182025_080351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008367/form4-03182025_080351.xml","form_type":"4"}},{"id":1199730,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-18T20:11:54.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":true,"shares":7475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported total includes an aggregate 825 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":29776,"source":{"system":"sec-edgar","filing":"0001415889-25-008367","document":"form4-03182025_080351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008367/form4-03182025_080351.xml","form_type":"4"}},{"id":1335548,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-11T21:05:54.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":1552,"price":12.9923,"value":20164.0496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.99 to $13.24 per share, inclusive."}],"balance_after":21476,"source":{"system":"sec-edgar","filing":"0001415889-24-028929","document":"form4-12112024_091251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028929/form4-12112024_091251.xml","form_type":"4"}},{"id":1335547,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-11T21:05:54.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":12114,"price":13.6878,"value":165814.0092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.41 to $14.22 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote (4)."}],"balance_after":23028,"source":{"system":"sec-edgar","filing":"0001415889-24-028929","document":"form4-12112024_091251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028929/form4-12112024_091251.xml","form_type":"4"}},{"id":1337168,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-11T00:01:47.000Z","date":"2024-12-06","kind":"sale","planned":false,"acquired":false,"shares":9696,"price":12.7775,"value":123890.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.93 to $13.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":35142,"source":{"system":"sec-edgar","filing":"0001415889-24-028891","document":"form4-12112024_121243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028891/form4-12112024_121243.xml","form_type":"4"}},{"id":1341577,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Performance Stock Units","published_at":"2024-12-05T21:21:07.000Z","date":"2024-12-03","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Half the award vests on December 3, 2024 and the remainder shall vest on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":6000,"derivative":{"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001415889-24-028398","document":"form4-12052024_091203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028398/form4-12052024_091203.xml","form_type":"4"}},{"id":1341576,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Performance Stock Units","published_at":"2024-12-05T21:21:07.000Z","date":"2024-12-03","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This award represents a grant of restricted stock units upon the achievement of certain performance criteria as certified by the Issuer's compensation committee on the Transaction Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Half the award vests on December 3, 2024 and the remainder shall vest on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":12000,"derivative":{"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001415889-24-028398","document":"form4-12052024_091203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028398/form4-12052024_091203.xml","form_type":"4"}},{"id":1341575,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-05T21:21:07.000Z","date":"2024-12-03","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44838,"source":{"system":"sec-edgar","filing":"0001415889-24-028398","document":"form4-12052024_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028398/form4-12052024_091203.xml","form_type":"4"}},{"id":1344962,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-12-03T21:14:20.000Z","date":"2024-12-01","kind":"exercise","planned":false,"acquired":false,"shares":33927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33,927 restricted stock units vest on December 1, 2024 and 12,357 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date."}],"balance_after":12357,"derivative":{"expiration_date":"2025-12-01","underlying":"Common Stock","underlying_shares":33927},"source":{"system":"sec-edgar","filing":"0001415889-24-028071","document":"form4-12032024_091216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028071/form4-12032024_091216.xml","form_type":"4"}},{"id":1344961,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-03T21:14:20.000Z","date":"2024-12-01","kind":"exercise","planned":false,"acquired":true,"shares":33927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported total includes an aggregate 2,313 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":38838,"source":{"system":"sec-edgar","filing":"0001415889-24-028071","document":"form4-12032024_091216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028071/form4-12032024_091216.xml","form_type":"4"}},{"id":1486730,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2024-06-07T20:37:02.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":24000,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001415889-24-015998","document":"form4-06072024_080658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924015998/form4-06072024_080658.xml","form_type":"4"}},{"id":1486729,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-07T20:37:02.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested or vests as to 1/48 of the total award on April 15, 2024, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":36000,"derivative":{"exercise_price":14.17,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001415889-24-015998","document":"form4-06072024_080658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924015998/form4-06072024_080658.xml","form_type":"4"}},{"id":1505434,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T20:15:34.000Z","date":"2024-05-20","kind":"exercise","planned":true,"acquired":false,"shares":8599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested or vests as to 1/48th of the total award on January 7, 2023, with 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":25801,"derivative":{"exercise_price":7.07,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":8599},"source":{"system":"sec-edgar","filing":"0001415889-24-014082","document":"form4-05222024_080500.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924014082/form4-05222024_080500.xml","form_type":"4"}},{"id":1505433,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-05-22T20:15:34.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":8599,"price":15.0398,"value":129327.2402,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 15, 2023 by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.16 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote"}],"balance_after":2598,"source":{"system":"sec-edgar","filing":"0001415889-24-014082","document":"form4-05222024_080500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924014082/form4-05222024_080500.xml","form_type":"4"}},{"id":1505432,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-05-22T20:15:34.000Z","date":"2024-05-20","kind":"exercise","planned":true,"acquired":true,"shares":8599,"price":7.07,"value":60794.93,"ownership":{"direct":true},"balance_after":11197,"source":{"system":"sec-edgar","filing":"0001415889-24-014082","document":"form4-05222024_080500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924014082/form4-05222024_080500.xml","form_type":"4"}},{"id":1556259,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-04-01T20:14:23.000Z","date":"2024-03-28","kind":"sale","planned":true,"acquired":false,"shares":100,"price":13.81,"value":1381.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 15, 2023 by the reporting person."}],"balance_after":2598,"source":{"system":"sec-edgar","filing":"0001415889-24-009532","document":"form4-04012024_080416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924009532/form4-04012024_080416.xml","form_type":"4"}},{"id":1556258,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-04-01T20:14:23.000Z","date":"2024-03-28","kind":"sale","planned":true,"acquired":false,"shares":5026,"price":13.1888,"value":66286.9088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 15, 2023 by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.62 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote"}],"balance_after":2698,"source":{"system":"sec-edgar","filing":"0001415889-24-009532","document":"form4-04012024_080416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924009532/form4-04012024_080416.xml","form_type":"4"}},{"id":1568614,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2024-03-20T00:29:06.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":7475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The award vested or vests as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":22425,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7475},"source":{"system":"sec-edgar","filing":"0001415889-24-008681","document":"form4-03202024_120354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924008681/form4-03202024_120354.xml","form_type":"4"}},{"id":1568613,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-03-20T00:29:06.000Z","date":"2024-03-19","kind":"sale","planned":false,"acquired":false,"shares":2349,"price":6.0986,"value":14325.6114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.94 to $6.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7724,"source":{"system":"sec-edgar","filing":"0001415889-24-008681","document":"form4-03202024_120354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924008681/form4-03202024_120354.xml","form_type":"4"}},{"id":1568612,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-03-20T00:29:06.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":true,"shares":7475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported total includes an aggregate 2,598 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":10073,"source":{"system":"sec-edgar","filing":"0001415889-24-008681","document":"form4-03202024_120354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924008681/form4-03202024_120354.xml","form_type":"4"}},{"id":1721651,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp Sec"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-12-05T21:09:41.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":46284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"33,927 restricted stock units will vest on December 1, 2024 and 12,357 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date."}],"balance_after":46284,"derivative":{"expiration_date":"2025-12-01","underlying":"Common Stock","underlying_shares":46284},"source":{"system":"sec-edgar","filing":"0001209191-23-057387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123057387/doc4.xml","form_type":"4"}},{"id":1721650,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-05T21:09:41.000Z","date":"2023-12-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":121100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 121,100 shares of Common Stock of the Issuer and in exchange issued to the reporting person 37,843 restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The canceled option vested as to 1/48th of the total award on April 15, 2022 and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":20.34,"expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":121100},"source":{"system":"sec-edgar","filing":"0001209191-23-057387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123057387/doc4.xml","form_type":"4"}},{"id":1721649,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-05T21:09:41.000Z","date":"2023-12-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 65,000 shares of Common Stock of the Issuer and in exchange issued to the reporting person 8,441 restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The canceled option vested as to 1/4th of the total award on February 16, 2022, and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":59.84,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-23-057387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123057387/doc4.xml","form_type":"4"}},{"id":1845190,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2023-06-23T20:45:11.000Z","date":"2023-06-21","kind":"sale","planned":true,"acquired":false,"shares":1948,"price":13.4765,"value":26252.222,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 22, 2023 by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.21 to $13.90 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-039428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123039428/doc4.xml","form_type":"4"}},{"id":1946963,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp Sec"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-17T20:37:28.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":29900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":29900,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":29900},"source":{"system":"sec-edgar","filing":"0001209191-23-019676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123019676/doc4.xml","form_type":"4"}},{"id":1946962,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp Sec"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-17T20:37:28.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":44800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on April 15, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":44800,"derivative":{"exercise_price":9.15,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":44800},"source":{"system":"sec-edgar","filing":"0001209191-23-019676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123019676/doc4.xml","form_type":"4"}}]}